CALR, JAK2 and MPL mutation status in Argentinean patients with BCR-ABL1- negative myeloproliferative neoplasms
Objectives: To establish the frequency of JAK2, MPL and CALR mutations in Argentinean patients with BCR-ABL1-negative myeloproliferative neoplasms (MPN) and to compare their clinical and haematological features. Methods: Mutations of JAK2V617F, JAK2 exon 12, MPL W515L/K and CALR were analysed in...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article artículo publishedVersion |
Lenguaje: | Inglés |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | http://hdl.handle.net/2133/19990 http://hdl.handle.net/2133/19990 |
Aporte de: |
id |
I15-R121-2133-19990 |
---|---|
record_format |
dspace |
institution |
Universidad Nacional de Rosario |
institution_str |
I-15 |
repository_str |
R-121 |
collection |
Repositorio Hipermedial de la Universidad Nacional de Rosario (UNR) |
language |
Inglés |
orig_language_str_mv |
eng |
topic |
Myeloproliferative Neoplasms Polycythemia Vera Thrombocythemia, Essential Primary Myelofibrosis Calreticulin JAK2V617F Thrombopoietin |
spellingShingle |
Myeloproliferative Neoplasms Polycythemia Vera Thrombocythemia, Essential Primary Myelofibrosis Calreticulin JAK2V617F Thrombopoietin Ojeda, Mara Jorgelina Bragós, Irma Margarita Calvo, Karina Williams, Gladis Marcela Carbonell, María Magdalena Pratti, Arianna Flavia CALR, JAK2 and MPL mutation status in Argentinean patients with BCR-ABL1- negative myeloproliferative neoplasms |
topic_facet |
Myeloproliferative Neoplasms Polycythemia Vera Thrombocythemia, Essential Primary Myelofibrosis Calreticulin JAK2V617F Thrombopoietin |
description |
Objectives: To establish the frequency of JAK2, MPL and CALR mutations in Argentinean
patients with BCR-ABL1-negative myeloproliferative neoplasms (MPN) and to compare their
clinical and haematological features.
Methods: Mutations of JAK2V617F, JAK2 exon 12, MPL W515L/K and CALR were analysed in 439
Argentinean patients with BCR-ABL1-negative MPN, including 176 polycythemia vera (PV), 214
essential thrombocythemia (ET) and 49 primary myelofibrosis (PMF).
Results: In 94.9% of PV, 85.5% ET and 85.2% PMF, we found mutations in JAK2, MPL or CALR.
74.9% carried JAK2V617F, 12.3% CALR mutations, 2.1% MPL mutations and 10.7% were triple
negative. In ET, nine types of CALR mutations were identified, four of which were novel. PMF
patients were limited to types 1 and 2, type 2 being more frequent.
Discussion: In ET, patients with CALR mutation were younger and had higher platelet counts
than those with JAK2V617F and triple negative. In addition, JAK2V617F patients had high
leucocyte and haemoglobin values compared with CALR-mutated and triple-negative
patients. In PMF, patients with mutant CALR were associated with higher platelet counts.
Conclusion: Our study underscores the importance of JAK2, MPL and CALR genotyping for
accurate diagnosis of patients with BCR-ABL1-negative MPN. |
format |
article artículo publishedVersion |
author |
Ojeda, Mara Jorgelina Bragós, Irma Margarita Calvo, Karina Williams, Gladis Marcela Carbonell, María Magdalena Pratti, Arianna Flavia |
author_facet |
Ojeda, Mara Jorgelina Bragós, Irma Margarita Calvo, Karina Williams, Gladis Marcela Carbonell, María Magdalena Pratti, Arianna Flavia |
author_sort |
Ojeda, Mara Jorgelina |
title |
CALR, JAK2 and MPL mutation status in Argentinean patients with BCR-ABL1- negative myeloproliferative neoplasms |
title_short |
CALR, JAK2 and MPL mutation status in Argentinean patients with BCR-ABL1- negative myeloproliferative neoplasms |
title_full |
CALR, JAK2 and MPL mutation status in Argentinean patients with BCR-ABL1- negative myeloproliferative neoplasms |
title_fullStr |
CALR, JAK2 and MPL mutation status in Argentinean patients with BCR-ABL1- negative myeloproliferative neoplasms |
title_full_unstemmed |
CALR, JAK2 and MPL mutation status in Argentinean patients with BCR-ABL1- negative myeloproliferative neoplasms |
title_sort |
calr, jak2 and mpl mutation status in argentinean patients with bcr-abl1- negative myeloproliferative neoplasms |
publisher |
Taylor & Francis |
publishDate |
2021 |
url |
http://hdl.handle.net/2133/19990 http://hdl.handle.net/2133/19990 |
work_keys_str_mv |
AT ojedamarajorgelina calrjak2andmplmutationstatusinargentineanpatientswithbcrabl1negativemyeloproliferativeneoplasms AT bragosirmamargarita calrjak2andmplmutationstatusinargentineanpatientswithbcrabl1negativemyeloproliferativeneoplasms AT calvokarina calrjak2andmplmutationstatusinargentineanpatientswithbcrabl1negativemyeloproliferativeneoplasms AT williamsgladismarcela calrjak2andmplmutationstatusinargentineanpatientswithbcrabl1negativemyeloproliferativeneoplasms AT carbonellmariamagdalena calrjak2andmplmutationstatusinargentineanpatientswithbcrabl1negativemyeloproliferativeneoplasms AT prattiariannaflavia calrjak2andmplmutationstatusinargentineanpatientswithbcrabl1negativemyeloproliferativeneoplasms |
bdutipo_str |
Repositorios |
_version_ |
1764820411230453763 |